Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of lycopene-grape seed extract composition in pharmacy

A technology of lycopene and grape seed is applied in the field of pharmaceutical use of a composition of lycopene and grape seed extract, and can solve the problems of complex compatibility of traditional Chinese medicine preparations, toxic and side effects of traditional Chinese medicine, and difficulty in obtaining affirmation of safety.

Inactive Publication Date: 2017-09-22
SINO NUTRACEUTICAL CO LTD
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Patents CN 104707102 A and CN 104491330 A all mentioned traditional Chinese medicine compositions, which stabilized the eyesight of patients with macular degeneration to a certain extent and alleviated the phenomenon of fundus bleeding. , stimulating effect, its long-term safety is difficult to be sure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of lycopene-grape seed extract composition in pharmacy
  • Application of lycopene-grape seed extract composition in pharmacy
  • Application of lycopene-grape seed extract composition in pharmacy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] prescription:

[0020]

[0021] Preparation:

[0022] The components are mixed, and then pressed into tablets by a method known in the art to obtain tablets, wherein: each tablet contains 15 mg of lycopene and 75 mg of grape seed extract.

Embodiment 2

[0024]

[0025] The preparation method is the same as that in Example 1 to obtain tablets, wherein the content of lycopene in each tablet is 20 mg, and the content of grape seed extract is 60 mg.

Embodiment 3

[0027] clinical research

[0028] (1) Case data: 180 cases (180 eyes) of patients with age-related macular degeneration selected from hospital wards and outpatient clinics, age: over 50 years old; clinical manifestations include vision loss or metamorphopsia; macular drusen , depigmentation or proliferation; typical CNV signs; subretinal hemorrhage, exudation, fibrous organized membrane.

[0029] They were randomly divided into experimental group 1, experimental group 2, control group 1 and control group 2. Among them, 160 cases in the experimental group, the oldest is 79 years old, the youngest is 55 years old, and the course of disease is 5-74 months; the experimental group is 260 cases, the oldest is 76 years old, the youngest is 55 years old, and the course of disease is 5-73 months; The oldest is 74 years old, the youngest is 55 years old, and the course of disease is 5-72 months; the control group is 260 cases, the oldest is 75 years old, the youngest is 54 years old, a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a lycopene-grape seed extract composition in treating age-related maculopathy; the lycopene-grape seed extract composition comprises, by weight, 1 part of lycopene and 2-10 parts of grape seed extract. Clinical tests prove that the lycopene-grape seed extract composition has significant effect in treating age-related maculopathy, and is applicable to the preparation of drugs and nutrients for treating and preventing age-related maculopathy. The application of the lycopene-grape seed extract composition has the advantage that the lycopene-grape seed extract composition is significantly effective in treating age-related maculopathy, is nutritional and free of side effects, and has the functions of age defying, cancer prevention and resisting, and chronic disease relieving or improving.

Description

technical field [0001] The present invention relates to a new indication of a nutritional composition of lycopene and grape seed extract. Background technique [0002] Age-related macular degeneration is a pathological manifestation of the human aging process in the eyes. With age, the incidence rate gradually increases. It is an important cause of low vision and blindness in people over 50 years old at home and abroad. Patients with age-related macular degeneration can manifest as symptoms such as blurred vision, metamorphopsia, decreased vision, central scotoma, and dark shadows in front of the eyes. At present, in modern medicine, there is no definite drug treatment for age-related macular degeneration, and no good method has been found to prevent the progression of the disease. Patents CN 104707102 A and CN 104491330 A all mentioned traditional Chinese medicine compositions, which stabilized the eyesight of patients with macular degeneration to a certain extent and alle...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/87A61P27/02A61P39/06A61P35/00A61P43/00A23L33/105A61K31/01
CPCA23L33/105A23V2002/00A61K31/01A61K36/87A61K2300/00A23V2200/30A23V2250/21A23V2200/318A23V2200/308A23V2200/302
Inventor 顾茂健苏健梅
Owner SINO NUTRACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com